Characterization of factors affecting the release of low-solubility drug from prolonged release tablets
Diclofenac sodium (2-[(2,6-dichlorophenyl)amino]benzeneacetic acid monosodium salt) was investigated as a low-solubility drug and Naklofen ® retard prolonged release tablets, containing 100 mg of diclofenac sodium as a prolonged release lipophilic matrix system using factorial design approach. First...
Saved in:
Published in: | Analytica chimica acta Vol. 502; no. 1; pp. 107 - 113 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Amsterdam
Elsevier B.V
23-01-2004
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!